• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 8
  3. Authors

Online ISSN: 2515-8260

Volume9, Issue8

Antimicrobial And Anticancer Activity Of A Noveld- Mannose Specific Lectin From The Flower, Ipomoea Pes-Caprae

    Nightingale Sheebaa Vinoliya Josephine Mary ArokiadhasIswarya . BaskaralingamVaseeharan . Mary MettildaBai .

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 8, Pages 1811-1830

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

            In the present study, a 35 kDa D-mannose specific lectin was purified from the flower extract of Ipomoea pes-caprae (IPL) by lactoferrin-Sepharose 4B in the econo column (Bio-Rad). Physico-chemical analysis revealed that lectin was stable the pH ranges from 6.5-9.5 and temperature ranges from 0°C-60°. The lectin was highly specific for rabbit erythrocytes. UV spectral analysis of lectin documented a characteristic peak at 230 nm and FTIR spectrum showed the IR absorption peaks correspond to amide I and II bands, carboxylic and O-H groups in the lectin. Antimicrobial activity of lectin was tested against four Gram positive bacteria, four Gram negative bacteria and four fungal pathogens. It was observed that the lectin was more effective with a maximum zone of inhibition of 22 mm and 19 mm against B. subtilis andA. flavus respectively.Moderate activities were observed against all the bacteria and fungus tested ranging from 12 mm to 18 mm. The IPL lectin was checked for its antiproliferative and cytotoxicity effect against three cancer cell lines and also with normal fibroblast cell line by MTT assay. The result shows MCF-7 was more sensitive to IPL with lowest IC50 value of 161.01 µg/ml and exhibit low toxicity against normal cells with IC50 value of 374.36 µg/ml. As a result, this research opens up new possibilities for lectin pharmacology.
Keywords:
    Lectin affinity chromatography mannose antimicrobial anticancer
  • PDF (1347 K)
  • XML
(2022). Antimicrobial And Anticancer Activity Of A Noveld- Mannose Specific Lectin From The Flower, Ipomoea Pes-Caprae. European Journal of Molecular & Clinical Medicine, 9(8), 1811-1830.
Nightingale Sheebaa; Vinoliya Josephine Mary; ArokiadhasIswarya .; BaskaralingamVaseeharan .; Mary MettildaBai .. "Antimicrobial And Anticancer Activity Of A Noveld- Mannose Specific Lectin From The Flower, Ipomoea Pes-Caprae". European Journal of Molecular & Clinical Medicine, 9, 8, 2022, 1811-1830.
(2022). 'Antimicrobial And Anticancer Activity Of A Noveld- Mannose Specific Lectin From The Flower, Ipomoea Pes-Caprae', European Journal of Molecular & Clinical Medicine, 9(8), pp. 1811-1830.
Antimicrobial And Anticancer Activity Of A Noveld- Mannose Specific Lectin From The Flower, Ipomoea Pes-Caprae. European Journal of Molecular & Clinical Medicine, 2022; 9(8): 1811-1830.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 11
  • PDF Download: 17
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus